[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100391888":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":62,"collaborators":18,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":18,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":18,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":18,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Nitazoxanide","EXPERIMENTAL","Nitazoxanide with standard protocol of treatment",[13],"Drug: Nitazoxanide",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","Standard protocol alone",null,[20],{"type":21,"name":9,"description":9,"armGroupLabels":22,"otherNames":23},"DRUG",[9],[24],"Parazoxanide, Nanazoxid",[26],{"name":27,"affiliation":28,"role":29},"sherief Abd-Elsalam, Ass. Prof.","ass. Prof. Tropical Medicine","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[37,55],{"facility":38,"status":39,"city":40,"state":18,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Tanta University, Assiut University","RECRUITING","Tanta","35111","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],31.00192,30.78847,{"lat":48,"lon":47},[51,53],{"name":52,"role":33,"phone":18,"phoneExt":18,"email":18},"Sherief Abd-Elsalam",{"name":54,"role":29,"phone":18,"phoneExt":18,"email":18},"Sherief Abd-Elsalam, ass. prof",{"facility":52,"status":39,"city":40,"state":18,"zip":18,"country":42,"countryCode":43,"cosmosGeoPoint":56,"geoPoint":58,"contacts":59},{"type":45,"coordinates":57},[47,48],{"lat":48,"lon":47},[60],{"name":61,"role":33,"phone":18,"phoneExt":18,"email":35},"sherief abd-elsalam",{"type":29,"investigatorFullName":52,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Ass. Prof. Tropical Medicine","100391888","phase-3-novel-regimens-in-covid-19-treatment-100391888",false,"NCT04382846","Novel Regimens in COVID-19 Treatment","Nitazoxanide in Treatment of COVID-19","Inclusion Criteria:\n\n* Patients with COVID-19 infection\n\nExclusion Criteria:\n\n* Allergy or contraindication to the drugs.","ALL","18 Years",{"count":74,"type":75},160,"ESTIMATED","INTERVENTIONAL",[78],"PHASE3","Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.",[81,82],"COVID","Corona Virus Infection","2020-12-02",{"date":85,"type":86},"2020-12-04","ACTUAL",{"date":88,"type":86},"2020-05-08",{"date":90,"type":75},"2030-12-01",{"name":5,"class":6},2]